@OxfordVaccineGroup is investigating a new vaccine against Bundibugyo ebolavirus. f you are aged between 18 and 55, in good health and able to attend regular face-to-face visits in Oxford, you may be eligible. We will reimburse you up to £1,200 for group 1 and up to £790 for group 2 for your time, travel and inconvenience. The study will last for one year.
Find out more and register your interest
Bulletin category
Weight
0